LOPERAMIDE BGR CONSEIL 2 mg, orodispersible tablet 12 tablets
Active ingredients: Loperamide hydrochloride
Commercialized according to BDPM
Orodispersible tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LOPERAMIDE BGR CONSEIL 2 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 12 comprimé(s)
- Marketing authorisation holder
- BIOGARAN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 3 Mar 2023
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65678867CIP73025258CIP133400930252581Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LOPÉRAMIDEcomprimé | 2 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.